Stereotactic Body Radiotherapy for Prostate Cancer: Where, When, and Who? A Bibliometric Analysis
CONCLUSION: The number of publications and citations on SBRT for prostate cancer has grown linearly in the last decades. The United States is the leading country in this research field, and the use of SBRT in oligometastatic disease, reirradiation, and salvage seems to be hot topics in this research field.PMID:34618725 | DOI:10.1097/COC.0000000000000869
Source: Clinical Prostate Cancer - Category: Cancer & Oncology Authors: Gustavo A Viani Andre G Gouveia Alexandre A Jacinto Fabio Y Moraes Source Type: research
More News: Canada Health | Cancer | Cancer & Oncology | Databases & Libraries | Italy Health | Prostate Cancer | Science | UK Health | Urology & Nephrology | USA Health